Latest Content

Six years after follicular lymphoma treatment, a follow-up CT scan brought encouraging news—but the fear of recurrence and uncertainty still linger.

Luciana Lopes Manfredini, of Einstein Hospital Israelita in São Paulo, Brazil, developed a triage scale for emergency cancer patients now being adopted across North and Latin America.

Melanie Diaz, DNP, NP-C, OCN, of St. Francis Cancer Institute, blends firm accountability with deep empathy to keep cancer patients engaged and empowered throughout treatment.

Diagnosed with limited-stage small-cell lung cancer, Tammy shares how treatment progress and a mindset shift helped her find hope.

The 10-3 vote came during a discussion in which the limitations of TIL therapy, the only approved option for this group of patients, were raised repeatedly.

After two cancer diagnoses, one survivor reflects on fear, healing, and why moving beyond the "battle" metaphor brought a new perspective.

The FDA approved Pluvicto with hormone therapy for PSMA-positive metastatic prostate cancer, helping delay disease progression in patients.

Patients with advanced biliary tract cancer lived longer on Imfinzi (durvalumab) plus chemotherapy than on chemotherapy alone, according to four-year follow-up data from the phase 3 TOPAZ-1 trial.

Tafinlar plus Mekinist extended progression-free survival to 12.8 months vs. 3.7 months with placebo in BRAF V600E-positive thyroid cancer.

Heather Prather shares her stage 4 non small cell lung cancer journey, finding hope, joy and support through the LiveLung community and cancer advocacy.

A simple balance exercise for cancer patients: the Drinking Bird. Learn how this single-leg move builds stability, strength, and confidence safely.

After 12 years cancer-free, a breast cancer survivor reflects on how her diagnosis inspired her daughters to make informed choices about their health.

Patients with advanced stomach cancer lived longer on sonesitatug vedotin than on standard treatment, according to new trial results.